WEBULL
WebtradeDownload

Did BWX Technologies Fall Catch You Out? What Investors Missed

Simply Wall St · 1d ago

If you had looked at BWX Technologies in October 2025 and decided to wait for a clearer entry instead of buying, the past year might feel like a risk you sidestepped. For BWX Technologies shareholders, the loss over the past year was 26.9%, including dividends. With analysts then split between high growth nuclear optimism and heavy reliance on U.S. defense contracts and regulation, which of those recorded assumptions would you have pressed hardest before committing capital?

Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.

The move put BWX Technologies in the middle of this trade. Scan 16 nuclear energy infrastructure stocks for other companies exposed to it.

The Argument You Would Have Been Weighing Up On BWX Technologies

The shares cost US$197 at the start of the period, and BWX Technologies sat between two sharply different stories that both sounded plausible.

On the bullish side, the Narrative pointed to a Fair Value of US$233 and leaned on clean energy trends. It assumed nuclear demand across government, medical, and commercial power could support high teens revenue growth and justify a P/E of 50.4x on 2028 earnings.

The bearish view put Fair Value at US$110 and focused on political and regulatory pressure. It highlighted the risk that shifting energy policies and public opposition to nuclear could disrupt project pipelines and leave BWX Technologies exposed to swings in U.S. defense spending.

NYSE:BWXT 1-Year Stock Price Chart
NYSE:BWXT 1-Year Stock Price Chart

What The Evidence Did To The BWX Technologies Argument

The most concrete development for BWX Technologies was a combination of firm contracts and visible project progress. Naval nuclear agreements of about US$1.4b, a Q2 2026 revenue figure of US$901.6m versus US$764.0m a year earlier, and higher profit supported the growth narrative, while a net margin move from 10.3% to 9.9% kept pressure on the high-margin assumptions. Overall, the evidence pointed in both directions.

The useful takeaway is straightforward. When an investment story relies on operating leverage and rich P/E multiples, it is worth tracking whether revenue, absolute profit and reported net margin are all moving in the same direction before applying that framework to another stock.

What You Would Be Paying For In BWX Technologies Today

BWX Technologies now trades at US$142 after the share price fell about 27% over the past year. The selected Narrative still places its Fair Value above that level, anchored in long-duration nuclear programs and a growing mix of higher margin work.

At this price, a buyer would be assuming that BWX Technologies converts its current backlog and microreactor and advanced fuel opportunities into sustained, profitable revenue over many years.

"Record $6 billion backlog (+70% YoY) and 23% quarter-over-quarter growth, driven by multi-year defense contracts, rapidly expanding opportunity pipeline, and accelerating nuclear energy/medical demand signal strong visibility into future revenue growth and earnings stability."

Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there

Which Company Could Surprise You Next?

This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.

  • Company 1 - 44% below our estimate - focuses on higher-margin data center hardware while exiting selected consumer projects.
  • Company 2 - 42% below our estimate - expands integrated LED display solutions as software deepens long-term customer engagement.
  • Company 3 - 46% below our estimate - integrates acquired satellite assets into defense contracts featuring semi-recurring connectivity services.

Those are three of them. See all 27 potentially undervalued companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.